Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C

ClinicalTrials.gov ID: NCT01389323

Public ClinicalTrials.gov record NCT01389323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 5:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label, Single Arm Evaluation of BMS-790052 (Daclatasvir) in Combination With Peg-Interferon Alfa-2a and Ribavirin in Black-African Americans, Latinos and White-Caucasians With Chronic Hepatitis C Genotype 1 Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the rates of sustained virologic response in each cohort (Black-African Americans, Latinos) in this study to historical rate.

Study identification

NCT ID
NCT01389323
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
448 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
Aug 31, 2013
Completion
Dec 31, 2013
Last update posted
Oct 11, 2015

2011 – 2014

United States locations

U.S. sites
35
U.S. states
14
U.S. cities
27
Facility City State ZIP Site status
Alabama Liver & Digestive Specialists (Alds) Montgomery Alabama 36116
Va Long Beach Healthcare System - 11 Long Beach California 90822
Axis Clinical Trials Los Angeles California 90036
Greater Los Angeles Healthcare System Los Angeles California 90073
University Of California, Davis Medical Center Sacramento California 95817
Ucsd Antiviral Research Center (Avrc) San Diego California 92103
Precision Research Institute, Llc San Diego California 92115
Medical Associates Research Group, Inc San Diego California 92123
Miami V.A. Healthcare System Maimi Florida 33125
University Of Miami Miami Florida 33136
Florida Hospital Transplant Center Orlando Florida 32804
Infectious Disease Research Institute, Inc Tampa Florida 33614
South Florida Center Of Gastroenterology, P.A. Wellington Florida 33414
Triple O Research Institute, P.A. West Palm Beach Florida 33401
Atlanta Medical Center Atlanta Georgia 30312
The Emory Clinic Atlanta Georgia 30322
Loyola University Medical Center Maywood Illinois 60153
Tulane University Health Sciences Center New Orleans Louisiana 70112
Mercy Medical Center Baltimore Maryland 21202
Digestive Disease Associates, P.A. Baltimore Maryland 21229
The Research Institute Springfield Massachusetts 01105
Digestive Health Center Ocean Springs Mississippi 39564
Montefiore Medical Center The Bronx New York 10467
University Of North Carolina At Chapel Hill School Of Med Chapel Hill North Carolina 27599
Carolinas Medical Center Charlotte North Carolina 28203
Carolinas Center For Liver Disease Statesville North Carolina 28677
Oregon Health & Science University Portland Oregon 97239
Texas Clinical Research Institute Arlington Texas 76012
Baylor College Of Medicine Houston Texas 77030
Liver Associates Of Texas Houston Texas 77030
Research Specialists Of Texas Houston Texas 77030
Texas Liver Institute San Antonio Texas 78215
Brooke Army Medical Center San Antonio Texas 78234
Metropolitan Research Annandale Virginia 22003
Mcguire D V A M C Richmond Virginia 23249

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01389323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2015 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01389323 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →